I agree that this site is using cookies. You can find further informations here.
X
Uchibori, Ken
37  results:
OpenAccess-fulltext X
Search for persons X
?
1

MIG6 loss confers resistance to ALK/ROS1 inhibitors in NSCL..:

Kondo, Nobuyuki ; Utsumi, Takahiro ; Shimizu, Yuki...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10807714/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
2

Real-World Outcome Analysis of Patients With Stage IV NSCLC..:

Ariyasu, Ryo ; Kakuto, Sho ; Miyadera, Keiki...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329142/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
3

A phase II feasibility study of carboplatin and nab‐paclita..:

Sakashita, Hiroyuki ; Uchibori, Ken ; Jin, Yasuto...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058300/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
4

Soluble PD-L1 works as a decoy in lung cancer immunotherapy..:

Sagawa, Ray ; Sakata, Seiji ; Gong, Bo...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765052/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
5

Characteristics of central nervous system progression in no..:

Sakamoto, Hiroaki ; Yanagitani, Noriko ; Manabe, Ryo...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714545/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
6

Monitoring epidermal growth factor receptor C797S mutation ..:

Ariyasu, Ryo ; Uchibori, Ken ; Sasaki, Takaaki...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177776/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
7

Microsecond-timescale MD simulation of EGFR minor mutation ..:

Yoshizawa, Takahiro ; Uchibori, Ken ; Araki, Mitsugu...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052404/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
8

Clinical influence of switching companion diagnostic tests ..:

Uchibori, Ken ; Takano, Natsuki ; Manabe, Ryo...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952781/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
9

Overcoming resistance by ALK compound mutation (I1171S + G1..:

Takahashi, Ken ; Seto, Yosuke ; Okada, Koutaroh...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049522/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
10

Poor efficacy of anti‐programmed cell death‐1/ligand 1 mono..:

Tozuka, Takehiro ; Kitazono, Satoru ; Sakamoto, Hiroaki...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471023/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
11

Drug resistance mechanisms in Japanese anaplastic lymphoma ..:

Yanagitani, Noriko ; Uchibori, Ken ; Koike, Sumie...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060465/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
12

Three-Dimensional Euler Fluid Code for Fusion Fuel Ignition..:

Nakamura, Hiroki ; Kawata, Shigeo ; Uchibori, Ken.
http://arxiv.org/abs/2004.03810.  , 2020
Link: http://arxiv.org/abs/200..
 
?
13

Association Between the Efficacy of Pembrolizumab and Low S..:

HASEGAWA, TSUKASA ; YANAGITANI, NORIKO ; NINOMIYA, HIRONORI...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652526/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
14

Dissociated responses at initial computed tomography evalua..:

Tozuka, Takehiro ; Kitazono, Satoru ; Sakamoto, Hiroaki...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066771/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
15

Brigatinib combined with anti-EGFR antibody overcomes osime..:

Uchibori, Ken ; Inase, Naohiko ; Araki, Mitsugu...
10.1038/ncomms14768.  , 2017
Link: http://hdl.handle.net/24..
 
1-15